Amarin seeks FDA nod to make Novasep a Vascepa API supplier

08/27/2013 | Pharmaceutical Business Review Online

Amarin filed a supplemental new-drug application with the FDA for approval to make Novasep an additional supplier of the active pharmaceutical ingredient for Vascepa, or icosapent ethyl. If approved, Novasep, through its subsidiary Finorga, would become the fourth supplier of the Vascepa's API.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC